Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Acquired Hemophilia A (a condition where the body's immune system attacks its own clotting proteins, making it hard to stop bleeding).
- People whose doctor has determined they have a medical need to receive the treatment called Obizur.
- People who are 18 years of age or older at the time they start Obizur treatment.
- People who have agreed to take part in the study and have signed a consent form.
Who may not be able to join:
- People who have a known allergy or sensitivity to any of the ingredients in Obizur.
- People who have Congenital Hemophilia A with Inhibitors (a hereditary bleeding disorder that is different from Acquired Hemophilia A).
- People for whom Obizur is listed as unsuitable or unsafe according to the official product guidelines (confirm with trial site).
- People who have taken part in another clinical trial involving a medicine or medical device within the 30 days before enrolling, or who plan to join another such trial while this study is ongoing.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Study Director, Takeda
Phone: +1-877-825-3327
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants With Adverse Events (AEs), Causality to AEs, Serious AEs (SAEs) and AEs of Special Interest (AESI); Number of Participants With Expected/Unexpected AEs and SAEs; Number of Participants With Adverse Drug Reactions (ADRs), Unexpected ADRs, Serious ADRs, Expected SADRs and Unexpected SADRs; Number of Participants With Special Situation Report (SSR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.